Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Post by canadafanon Oct 23, 2023 8:13am
389 Views
Post# 35695821

Not one, but two positive news items out today

Not one, but two positive news items out today

Not one, but two very positive N.R. Out today from ESMO in Spain.
The FUD engineers will have to crank up the steam, in the boiler room today.
Medical data aside, most significant comment.
" we look forward to advancing the phase 3 trial with PanCan ASAP".
(Paraphrasing)
they met criteria to advance colorectal cancer trial to next level. 

they surpassed & show durability with previous pancreatic results.
All great news 
The shorts may work hard to keep SP down,, however Phase 3 will be announced.
Not likely today, but soon enough.
People need to clearly understand the ESMO data etc, was part of a co- therapy with Roche.
It may take a few days to sink in & gain traction.
Todays news on- top- off , the $5million grant from PanCan is exactly what Onc needs for stronger negotiating position.
great week all.
stay safe, healthy & enjoy our beautiful country.

my handle Canadafan is well meaning.


 

<< Previous
Bullboard Posts
Next >>